# B6 Z# I* i: QNature 461, 614-620 (1 October 2009) | doi:10.1038/nature08356 3 q4 r1 J; P2 ~4 x7 A R% k, U6 [2 T . q% }6 J' l$ M6 HTankyrase inhibition stabilizes axin and antagonizes Wnt signalling3 \/ v# Z9 M1 ?6 l
; v; b7 A- ^( ?
Shih-Min A. Huang1, Yuji M. Mishina1, Shanming Liu1, Atwood Cheung1, Frank Stegmeier1, Gregory A. Michaud1, Olga Charlat1, Elizabeth Wiellette1, Yue Zhang1, Stephanie Wiessner1, Marc Hild1, Xiaoying Shi1, Christopher J. Wilson1, Craig Mickanin1, Vic Myer1, Aleem Fazal1, Ronald Tomlinson1, Fabrizio Serluca1, Wenlin Shao1, Hong Cheng1, Michael Shultz1, Christina Rau2, Markus Schirle2,4, Judith Schlegl2, Sonja Ghidelli2, Stephen Fawell1, Chris Lu1, Daniel Curtis1, Marc W. Kirschner3, Christoph Lengauer1,4, Peter M. Finan1, John A. Tallarico1, Tewis Bouwmeester2,4, Jeffery A. Porter1, Andreas Bauer2,4 & Feng Cong19 i7 O" Z4 M$ _3 m! E
# e7 L. n- K- S2 L
1 Novartis Institutes for Biomedical Research, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, USA Y! T. ?% J' d' j/ E
2 Cellzome AG, Meyerhofstrasse 1, D-69117 Heidelberg, Germany 1 S: p" ?# g9 ZDepartment of Systems Biology, Harvard Medical School, Boston, Massachusetts 02115, USA 7 L- o. R$ _0 W9 V6 u/ D( P
3 Present addresses: Novartis Institutes for Biomedical Research, CH-4002 Basel, Switzerland (T.B., A.B.); Novartis Institutes for Biomedical Research, Cambridge, Massachusetts 02139, USA (M. Sc.); Sanofi-Aventis, 94403 Vitry-sur-Seine, France (C.L.).. q0 U" J w8 D
Correspondence to: Feng Cong1 Correspondence and requests for materials should be addressed to F.C. : l' Z) ?8 S3 M' e* Y; p6 z, Y- o2 C3 b
The stability of the Wnt pathway transcription factor -catenin is tightly regulated by the multi-subunit destruction complex. Deregulated Wnt pathway activity has been implicated in many cancers, making this pathway an attractive target for anticancer therapies. However, the development of targeted Wnt pathway inhibitors has been hampered by the limited number of pathway components that are amenable to small molecule inhibition. Here, we used a chemical genetic screen to identify a small molecule, XAV939, which selectively inhibits -catenin-mediated transcription. XAV939 stimulates -catenin degradation by stabilizing axin, the concentration-limiting component of the destruction complex. Using a quantitative chemical proteomic approach, we discovered that XAV939 stabilizes axin by inhibiting the poly-ADP-ribosylating enzymes tankyrase 1 and tankyrase 2. Both tankyrase isoforms interact with a highly conserved domain of axin and stimulate its degradation through the ubiquitin-proteasome pathway. Thus, our study provides new mechanistic insights into the regulation of axin protein homeostasis and presents new avenues for targeted Wnt pathway therapies.作者: zzdqyaya 时间: 2009-10-6 09:41
学习一下,谢谢提供这么好的信息。作者: 轩辕之客 时间: 2009-10-8 13:58
本帖最后由 轩辕之客 于 2009-10-8 14:09 编辑 . f$ ~, O# ~" P' Q4 l6 } ) X4 h- [$ X% R. [9 p N8 ]) U附上原文作者: xiaomao_zhoubo 时间: 2010-2-4 03:54